@FierceMedDev: Integra LifeSciences lays off 49 in Massachusetts as part of facility consolidation drive. Article | Follow @FierceMedDev
@VarunSaxena2: UPDATED w/ $GE response GE recalls 10,000+ MRI systems after FDA deems them potentially deadly, citing poor training. Article | Follow @VarunSaxena2
@EmilyWFierce: Check out our weekly roundup of FierceLifeSciences news here! Newsletter | Follow @EmilyWFierce
> Coronary plaque diagnostics and treatment player Infraredx has postponed its $56 million IPO, making it at least the third diagnostics company to do so this month. More
> Australian startup Saluda Medical raised a $10 million Series B round to support clinical testing and marketing for its Evoke spinal cord stimulation system to treat chronic pain of the trunk and limbs. Release
> Dr. Peter Nightingale has been appointed as chairman of the U.K.'s newly formed Devices Expert Advisory Committee of the Medicines and Healthcare products Regulatory Agency. The new committee is expected to provide independent, expert strategic advice to the agency in support of its role to ensure that medical devices are acceptably safe and are used both safely and effectively. Statement
> Augmented reality helmet maker Daqri has acquired headband electroencephalogram (EEG) device producer Melon for an undisclosed amount. Story
Biotech News
@FierceBiotech: EuroBiotech Report: Novartis makes Israel a priority, U.K. dreams up Alzheimer's R&D hub, Shire defends tax model. More | Follow @FierceBiotech
@JohnCFierce: ICYMI: I love this Pronutria story. VC insiders, star scientist, homeostasis focus on oral biologics. It's what makes Boston/Cambridge special. Article | Follow @JohnCFierce
@DamianFierce: Cerecor is repurposing an old $LLY antidepressant for addiction. Release | Follow @DamianFierce
> Ariad activists rabble for Berger's job and mount a proxy fight. Story
> Novo Nordisk's game-changing oral diabetes drug clears Phase II. Article
> Biotech bonanza helps Bessemer roll out a $1.6B venture fund. Report
Pharma News
@FiercePharma: Sanofi names Paris-trained Olivier Brandicourt CEO. He will begin at Sanofi April 2. Report | Follow @FiercePharma
@CarlyHFierce: ICYMI earlier: Protein Sciences halts Connecticut expansion in response to governor's use of rival flu shot. FierceVaccines story | Follow @CarlyHFierce
> Valeant closing in on $160-per-share Salix deal: Reuters. More
> Ex-Merck analyst pleads guilty to insider trading. Item
> Sanofi makes it official--Brandicourt is its man. Report